Sobre 7 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the full record of transactions filed by Traversa Sergio. Officer active across 1 company, notably Relmada Therapeutics, INC.. In total, 10 filings have been recorded. Split: 9 buys · 0 sell. Total volume traded: €1.8m. Activity tracked since 30 June 2022. The latest transaction was filed on 9 September 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Traversa Sergio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16.012 títulos@ 16,00 US$36.6% de su flujoCommon StockSEC:0001213900-22-037231:0
10 de 10 declaraciones
About Traversa Sergio
TRAVERSA SERGIO is a declarant with 8 filings in total. In the 8 sampled recent filings, all linked to Relmada Therapeutics, INC. (XNAS) where he is Chief Executive Officer, buys amount to EUR 1085152 and sells to EUR 0, with a period running from 2022-07-05 to 2025-12-16. The modal transaction nature is Acquisition.